April 25, 2024
Market Now
GC LabCell acquires patent for culturing method
[DISCLOSURE] Green Cross LabCell (144510) announced on Jan. 13 that it has obtained a patent for a method for preparation of natural killer cells using T cells.
“We will be able to use 100 percent of the raw material for NK cell cultivation instead of using a portion as a supporting cell. As the natural killer cells will be manufactured in larger quantities, we expect it to be useful for commercialization,” said the company.
(theinvestor@heraldcorp.com)
“We will be able to use 100 percent of the raw material for NK cell cultivation instead of using a portion as a supporting cell. As the natural killer cells will be manufactured in larger quantities, we expect it to be useful for commercialization,” said the company.
(theinvestor@heraldcorp.com)
